Seres Therapeutics, Inc. financial data

Symbol
MCRB on Nasdaq
Location
Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 163 % +7.09%
Quick Ratio 37.2 %
Debt-to-equity 320 %
Return On Equity 15.3 % -74.8%
Return On Assets 3.65 %
Operating Margin -347K % -654942%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9.05M shares -94.7%
Common Stock, Shares, Outstanding 8.76M shares -94.9%
Entity Public Float 87.1M USD -81.2%
Common Stock, Value, Issued 9K USD -94.7%
Weighted Average Number of Shares Outstanding, Basic 8.76M shares +14.8%
Weighted Average Number of Shares Outstanding, Diluted 8.77M shares +14.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 351K USD
Revenue from Contract with Customer, Excluding Assessed Tax 351K USD
Research and Development Expense 50.2M USD -6.04%
General and Administrative Expense 44.1M USD -8.67%
Operating Income (Loss) -103M USD +53.4%
Nonoperating Income (Expense) 109M USD
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent 5.39M USD -90.8%
Earnings Per Share, Basic 0 USD/shares -57.7%
Earnings Per Share, Diluted 0 USD/shares -58.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 47.6M USD -28.7%
Accounts Receivable, after Allowance for Credit Loss, Current 351K USD
Inventory, Net 53M USD +892%
Assets, Current 51.5M USD -29.3%
Property, Plant and Equipment, Net 8.58M USD -31.7%
Operating Lease, Right-of-Use Asset 74.7M USD -9.94%
Other Assets, Noncurrent 31K USD -93.3%
Assets 143M USD -19.7%
Accounts Payable, Current 1.68M USD -79.7%
Employee-related Liabilities, Current 4.44M USD -46.3%
Liabilities, Current 22.4M USD -65.4%
Operating Lease, Liability, Noncurrent 75.3M USD -11.6%
Other Liabilities, Noncurrent 2.01M USD +13%
Liabilities 99.8M USD -35.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -957M USD +0.56%
Stockholders' Equity Attributable to Parent 43.7M USD +82.7%
Liabilities and Equity 143M USD -19.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 26.9M USD
Net Cash Provided by (Used in) Financing Activities 1.18M USD -93.7%
Net Cash Provided by (Used in) Investing Activities -34M USD -54739%
Common Stock, Shares Authorized 360M shares 0%
Common Stock, Shares, Issued 8.76M shares -94.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 56.3M USD -26.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 310M USD -0.98%
Deferred Tax Assets, Gross 331M USD -3.25%
Operating Lease, Liability 85.3M USD -8.93%
Payments to Acquire Property, Plant, and Equipment 34K USD -45.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 136K USD +62.1%
Lessee, Operating Lease, Liability, to be Paid 123M USD -13.6%
Property, Plant and Equipment, Gross 65M USD +0.33%
Operating Lease, Liability, Current 9.92M USD +18.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.6M USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 20M USD +2.78%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 38M USD -22.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 20.9M USD +1.37%
Deferred Tax Assets, Operating Loss Carryforwards 156M USD +9.58%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 14M USD +3.59%
Lessee, Operating Lease, Liability, to be Paid, Year Four 20.1M USD -3.5%
Operating Lease, Payments 17.6M USD -3.99%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 4.26M USD -29.1%
Share-based Payment Arrangement, Expense 11.4M USD -48.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%